The effect of neuropsychiatric medication on pediatric nonalcoholic fatty liver disease

• Principais autores: Jamie L. Ryan (Autor), Ashley K. Sherman (Autor), Daniel E. Heble (Autor), Craig A. Friesen (Autor), James F. Daniel (Autor), Ryan T. Fischer (Autor), Voytek Slowik (Autor)
• Formato: Livro
• Publicado em: Wiley, 2022-09-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Abstract Obese and overweight children are at risk of developing nonalcoholic fatty liver disease (NAFLD), which can lead to steatohepatitis, cirrhosis, and liver transplantation. Neuropsychiatric conditions affect an increasing proportion of children and often require neuropsychiatric medications (...